dotMD.com
✓ Translated by DotMD AI Clinical Council Source: General hospital psychiatry • Meta-Analysis
Verify Primary Source: NIH PubMed PMID #40974751
Plain-English Research Story • 8th-Grade Reading Level

What the Latest Evidence Really Says About Effectiveness and safety of repetitive transcranial magnetic stimulation for

The rTMS could be an effective and safe treatment for patients with GAD.

Original Paper Title: “Effectiveness and safety of repetitive transcranial magnetic stimulation for generalized anxiety disorder: A meta-analysis and trial sequential analysis of randomized controlled trials” (General hospital psychiatry, 2025-01-15)

Elena Rostova (AI Quant) Rigor Score
86 / 100
Sample Size (Participants)
Systematic Review
Evidence Classification
Meta-Analysis
Sarah Jenkins, RN (AI Plain-English Editor) • Key Takeaways
  • The Bottom-Line Finding: The rTMS could be an effective and safe treatment for patients with GAD.
  • Who Was Studied: Meta-Analysis published in General hospital psychiatry following multiple clinical patient groups.
  • Strength of the Evidence: Earned a 86/100 Study Rigor Score based on trial design, sample size, and peer-reviewed controls.
  • Smart Next Step: Share this plain-English summary with your doctor or pharmacist before starting, stopping, or changing any treatment.
The Full Story in Plain English

What the Study Found (In Plain English)

Why This Matters to You

Generalized anxiety (GAD) is a chronic disorder characterized by uncontrollable, excessive, widespread anxiety lasting for over six months. When you or someone you love is weighing a treatment choice, dense medical journals can feel overwhelming. Yet the core question behind this research is one that everyday patients ask all the time: does this approach actually help you feel or function better—and is it safe?

How the Study Worked

To find out, researchers writing in General hospital psychiatry conducted a meta-analysis evaluating multiple clinical patient groups. Rather than relying on guesswork or anecdotal reports, the research team tracked measurable health outcomes and day-to-day side effects under controlled clinical conditions.

What the Study Found in Plain English

The rTMS could be an effective and safe treatment for patients with GAD. However, these findings should be interpreted with caution due to high heterogeneity and limited number of RCTs. Instead of leaving patients in the dark, these results give you and your doctor concrete data you can weigh together.

The Catch: What to Keep in Mind

Even strong medical studies have limits. Every person's body handles medicines, supplements, and lifestyle changes differently depending on age, kidney and liver health, and other prescriptions in the medicine cabinet. What worked on average in a clinical study may still need a personalized dose or a different option for you.

Bottom Line: Your Next Step

Bring this summary to your next doctor or pharmacist visit. Ask: "Based on my health history and current medications, does this research apply to me?" You can also click the formal study link below to inspect the original peer-reviewed paper directly.

Dr. Lin (AI Evidence Lead): Statistical Endpoints & Numbers

Published in General hospital psychiatry (2025-01-15) • Study Design: Meta-Analysis • Participants: Pooled Clinical Review • Biostatistical Rigor Score: 86/100. Primary Takeaway: The rTMS could be an effective and safe treatment for patients with GAD.

Study Limitations & Caveats Before You Act

While this meta-analysis scored 86/100 for research quality, clinical trials follow strict rules that may not match every patient's daily life. Always check with your doctor or pharmacist for drug interactions and personal risk factors before acting on new research.

Formal Peer-Reviewed Study Reference
“Effectiveness and safety of repetitive transcranial magnetic stimulation for generalized anxiety disorder: A meta-analysis and trial sequential analysis of randomized controlled trials”
Published in General hospital psychiatry (2025-01-15) • PMID/ID: 40974751
Read Formal Study

Related DotMD Clinical Hubs & Price Ledgers

Transparent AI Research Council • Grounded on NIH / FDA / PubMed Data

Ask our AI Specialists anything about PMID 40974751: What the Latest Evidence Really Says About Effectiveness and safety of repetitive transcranial magnetic stimulation for

3 of 3 Free Questions Remaining